Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- Alerts, recalls and safety information: medicines and medical devices
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Marketing authorisations and licensing guidance
- Product information about medicines
- Medical devices regulation and safety
- Latest information for patients
- MHRA guidance on coronavirus (COVID-19)
- About MHRA
- All MHRA services and information
Featured
Manchester family locked up for illegal sale and supply of unlicensed medicines worth £1.5m
Press release
Three men have been sentenced to a total of three years at Manchester Crown Court after pleading guilty to the illegal sale and supply online of prescription-only medicines and controlled Class B and Class C drugs with a street value of more than £1.5m following investigations by the Medicines and Healthcare products Regulatory Agency (MHRA).
Patients can be reassured that Fluenz nasal spray vaccines remain safe and effective when used within the revised expiry dates.
The Medicines and Healthcare products Regulatory Agency’s (MHRA) Criminal Enforcement Unit (CEU) seized hundreds of thousands of doses of suspected illegally traded medicines, including powerful prescription-only medicines, following coordinated raids at two residential and two business premises across North Manchester.
MHRA instructs health organisations to prepare now for new measures to reduce ongoing serious harms of valproate
Press release
Other effective medicines are available for epilepsy and bipolar disorder and valproate should only be used if these don’t work or aren’t suitable for an individual patient
MHRA tells patients and healthcare professionals to stop using affected gels and retailers told to withdraw affected products.
IRP is expected to further help bringing life-saving new medicines to UK patients from 1 January 2024
Latest from the Medicines and Healthcare products Regulatory Agency
What we do
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Transparency and freedom of information releases
Our management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA
10 South Colonnade
London
E14 4PU
United Kingdom
During office hours:
020 3080 7651 (08:30 - 17:00)
Out of office hours:
07770 446 189 (17:00 - 08:30)
Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhragovuk.
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
10 South Colonnade
London
E14 4PU
United Kingdom